by The Protein A Resin market is estimated to be valued at US$ 656.9 Mn in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Protein A resin is immobilized Protein A used for the purification of monoclonal and polyclonal antibodies. Protein A has a high affinity for immunoglobulin G (IgG) antibodies. It is widely used to purify monoclonal antibodies which are used in various therapeutic areas such as oncology, autoimmune diseases, and infectious diseases among others.
Market Dynamics:
Growing demand for monoclonal antibodies is a major factor driving growth of the protein A resin market. Monoclonal antibodies find application in various therapeutic areas owing to advantages such as high specificity and affinity for a particular antigen. According to Coherent Market Insights analysis, global monoclonal antibodies market was valued at US$ 123.0 billion in 2019 and is estimated to witness a CAGR of 8.4% during the forecast period. Increasing research and development activities in biopharmaceutical companies to develop novel monoclonal antibodies is also boosting growth of the protein A resin market. Additionally, requirement to improve efficiency and yield during purification process of monoclonal antibodies has led biopharmaceutical companies to adopt affinity ligands such as protein A resin.
SWOT Analysis
Strength: Protein A Resin helps in antibody purification in lesser time leading to higher productivity. It offers high binding capacity and selectivity for antibodies. It delivers highly pure monoclonal antibodies required for various biotherapeutic applications.
Weakness: Protein A Resin requires buffers and sanitizers for cleaning and sanitization during purification process, increasing the overall cost. Leaching of Protein A from the resin matrix is another issue reducing resin lifespan.
Opportunity: Growing biopharmaceutical industry and increasing research in monoclonal antibody therapeutics offer significant growth opportunities. Rising demand for affinity chromatography resins from developing biologics also provides opportunities.
Threats: Introduction of novel affinity ligands can replace Protein A Resin. Stringent regulations surrounding the applications may also threaten the market.
Key Takeaways
The Global Protein A Resin Market Growth is expected to witness high, exhibiting CAGR of 8.5% over the forecast period, due to increasing demand for biotherapeutic drugs and monoclonal antibodies. Rising research activities in biopharmaceutical industry is further fuelling the market growth.
The North American region currently dominates the Protein A Resin market and is expected to continue its dominance during the forecast period. This is attributed to advance biotechnology industry and presence of major players in the region. Asia Pacific region is expected to grow at fastest pace owing to expanding biopharmaceutical sector, growing genomics and proteomics research in countries like China and India.
Key players operating in the Protein A Resin market are GE Healthcare, Thermo Fisher Scientific, Repligen, Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd. Major players are focusing on new product launches with improved performance and expanded production facilities to cater to growing demand
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
